• HOME (current)
  • MEETINGS ARCHIVE
    2022 RANZCO 2019 RANZCO 2018 RANZCO 2017 RANZCO 2016 RANZCO 2015 RANZCO 2014 RANZCO 2013 RANZCO
  • ADVANCED SEARCH
  • 2016 RANZCO HANDBOOK
Home > 2022 RANZCO > UVEITIS

Session : UVEITIS


SESSION INFORMATION

Date:      -

Time:      -

Meeting: 2022 RANZCO

ABSTRACT NUMBER : NA
Retrospective analysis of toxoplasmosis retinochoroiditis management in Auckland
ABSTRACT NUMBER : NA
Occurrence of infectious uveitis following local triamcinolone and/or methotrexate injections: A case series
ABSTRACT NUMBER : NA
Efficacy and safety of intracameral triamcinolone acetonide in uveitic cataract surgery
ABSTRACT NUMBER : NA
Risks and complications of cataract surgery in uveitis
ABSTRACT NUMBER : NA
Idiopathic retinal vasculitis, aneurysms and neuroretinitis: Clinical improvement with infliximab
ABSTRACT NUMBER : NA
Endogenous endophthalmitis: A 21-year review of cases at a tertiary eye care centre
ABSTRACT NUMBER : NA
Intravitreal injection of COX-2 acetylating immunoresolvents for the treatment of ocular inflammation: In vitro assessment in THP-1-derived macrophages and in vivo assessment in a rat model of endotoxin-induced uveitis
ABSTRACT NUMBER : NA
Uveitis and scleritis – The risk of mortality following the first presentation
ABSTRACT NUMBER : NA
Ibrutinib-related uveitis: A case series and discussion of ocular toxicities secondary to oral chemotherapeutic agents
ABSTRACT NUMBER : NA
Ocular involvement in Behcet’s disease: How often is the diagnosis delayed at first presentation, and does it make a difference?
Advanced Search

MOST VIEWED ABSTRACTS


  • This Week
  • This Month
  • All Time

    IRREVERSIBLE LENALIDOMIDE RELATED OPTIC NEUROPATHY IN A PATIENT WITH CHRONIC MYELOID LEUKAEMIA

    A cost-effectiveness analysis of AcrySof IQ vivity intraocular lens from private health fund perspective in Australia

    Efficacy and safety of intravitreal pegcetacoplan in geographic atrophy: Results from the phase 3 DERBY and OAKS trials

    Efficacy and safety of intravitreal pegcetacoplan in geographic atrophy: Results from the phase 3 DERBY and OAKS trials

    A cost-effectiveness analysis of AcrySof IQ vivity intraocular lens from private health fund perspective in Australia

    VERTICAL PRISM FUSION RANGES IN A NORMAL POPULATION

    IRREVERSIBLE LENALIDOMIDE RELATED OPTIC NEUROPATHY IN A PATIENT WITH CHRONIC MYELOID LEUKAEMIA

    A cost-effectiveness analysis of AcrySof IQ vivity intraocular lens from private health fund perspective in Australia

    A CASE OF GLAUCOMA IN HEREDITARY SPHEROCYTOSIS

RECENT MEETINGS


2022 RANZCO, 52nd Annual Scientific Congress of the Royal Australian and New Zealand College of Ophthalmologists
25 February – 1 March 2022
Brisbane Convention & Exhibition Centre (BCEC)
2019 RANZCO, 51st Annual Scientific Congress of the Royal Australian and New Zealand College of Ophthalmologists
08 November – 12 November 2019
Sydney, Australia

ARCHIVES

© COPYRIGHT 2016 The Royal Australian and New Zealand College of Ophthalmologists